Libo Xu

Discovery of a Potent, Highly Selective, and Orally Efficacious Small-Molecule Activator of the Insulin Receptor

Kun Liu, Libo Xu, Deborah Szalkowski et al. · Journal of Medicinal Chemistry · 2000 · 87 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators

Sajjad A. Qureshi, Victor Ding, Zhihua Li et al. · Journal of Biological Chemistry · 2000 · 67 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Discovery of (2<i>R</i>)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume

John J. Acton, Taro E. Akiyama, Ching H. Chang et al. · Journal of Medicinal Chemistry · 2009 · 52 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia

Kun Liu, Libo Xu, Joel P. Berger et al. · Journal of Medicinal Chemistry · 2005 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides

Libo Xu, Amy K. Farthing, James F. Dropinski et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7